ELMD - Electromed Inc Stock Price, Fair Value and News

17.60USD+0.21 (+1.21%)Market Closed

Market Summary

USD17.60+0.21

Market Closed

1.21%

ELMD Stock Price

View Fullscreen

ELMD RSI Chart

ELMD Valuation

Market Cap

149.6M

Price/Earnings (Trailing)

38.01

Price/Sales (Trailing)

2.89

EV/EBITDA

22.27

Price/Free Cashflow

40.11

ELMD Price/Sales (Trailing)

ELMD Profitability

Operating Margin

76.51%

EBT Margin

10.32%

Return on Equity

9.76%

Return on Assets

8.38%

Free Cashflow Yield

2.49%

ELMD Fundamentals

ELMD Revenue

Revenue (TTM)

51.7M

Rev. Growth (Yr)

16.71%

Rev. Growth (Qtr)

11.08%

ELMD Earnings

Earnings (TTM)

3.9M

Earnings Growth (Yr)

71.34%

Earnings Growth (Qtr)

980%

Breaking Down ELMD Revenue

Last 7 days

6.1%

Last 30 days

7.7%

Last 90 days

73.0%

Trailing 12 Months

67.1%

How does ELMD drawdown profile look like?

ELMD Financial Health

Current Ratio

5.97

ELMD Investor Care

Shares Dilution (1Y)

1.07%

Diluted EPS (TTM)

0.45

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	45.7M	48.1M	49.7M	51.7M
2022	39.9M	41.7M	42.3M	43.8M
2021	33.2M	35.8M	37.8M	38.5M
2020	34.2M	32.5M	32.2M	33.1M
2019	30.6M	31.3M	32.3M	32.9M
2018	27.7M	28.3M	29.3M	30.3M
2017	24.3M	25.9M	26.6M	27.2M
2016	22.5M	23.0M	23.5M	23.6M
2015	18.8M	19.4M	19.6M	21.0M
2014	14.9M	15.5M	16.8M	18.2M
2013	15.7M	15.1M	14.5M	14.1M
2012	19.9M	19.5M	18.2M	17.2M
2011	0	19.0M	20.2M	20.3M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Electromed Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 01, 2024	cunniff james l.	bought	137,250	15.25	9,000	ceo and president
Dec 14, 2023	summers andrew	bought	302,368	10.5	28,797	-
Dec 01, 2023	fluet gregory	acquired	-	-	3,000	-
Dec 01, 2023	walsh andrea m.	acquired	-	-	3,000	-
Dec 01, 2023	erickson stan k.	acquired	-	-	3,000	-
Dec 01, 2023	summers andrew	acquired	-	-	3,000	-
Dec 01, 2023	tune kathleen a	acquired	-	-	3,000	-
Dec 01, 2023	galatowitsch joseph l.	acquired	-	-	3,000	-
Dec 01, 2023	skarvan kathleen	acquired	-	-	3,000	-
Nov 21, 2023	cunniff james l.	bought	10,560	10.56	1,000	ceo and president

Which funds bought or sold ELMD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 29, 2024	COMMONWEALTH EQUITY SERVICES, LLC	sold off	-100	-114,000	-	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	new	-	-	-	-%
Apr 12, 2024	Carlson Capital Management	sold off	-100	-132,382	-	-%
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	187,838	3,941,000	-%
Feb 15, 2024	PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.	reduced	-0.38	200,261	4,552,590	0.27%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	new	-	167,839	167,839	-%
Feb 14, 2024	CITADEL ADVISORS LLC	sold off	-100	-133,979	-	-%
Feb 14, 2024	Royal Bank of Canada	reduced	-5.22	-7,000	1,532,000	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	unchanged	-	56,544	1,186,330	0.03%

Are Funds Buying or Selling ELMD?

Are funds buying ELMD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ELMD

No. of Funds

Unveiling Electromed Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	winn george h.	5.2%	446,303	SC 13G/A
Feb 13, 2024	radoff bradley louis	1.9%	165,000	SC 13G/A
Feb 14, 2023	radoff bradley louis	7.3%	68,000	SC 13G/A
Feb 14, 2023	skarvan kathleen	5.3%	469,072	SC 13D/A
Feb 13, 2023	punch & associates investment management, inc.	4.91%	416,515	SC 13G/A
Jul 12, 2022	skarvan kathleen	5.4%	477,312	SC 13D/A
Jul 11, 2022	skarvan kathleen	5.4%	477,312	SC 13D
May 26, 2022	radoff family foundation	0.8%	67,500	SC 13G
Feb 14, 2022	punch & associates investment management, inc.	5.10%	436,735	SC 13G
Sep 27, 2021	summers value fund lp	3.7%	320,224	SC 13D/A

Recent SEC filings of Electromed Inc

View All Filings

Date Filed	Form Type	Document
Mar 05, 2024	4	Insider Trading
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	8-K	Current Report
Feb 13, 2024	10-Q	Quarterly Report

Peers (Alternatives to Electromed Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	184.5B	40.1B	-6.77%	-4.63%	32.24	4.6	-8.12%	-17.45%
BDX	67.6B	19.5B	-5.19%	-11.58%	53.79	3.47	4.02%	-22.04%
ALGN	21.4B	3.9B	-13.89%	-11.01%	48.02	5.53	3.42%	23.09%
BAX	20.5B	14.8B	-5.55%	-14.80%	7.71	1.38	2.12%	209.17%
MID-CAP
ATR	9.6B	3.5B	0.34%	19.07%	30.58	2.7	6.16%	35.06%
HSIC	8.8B	12.3B	-8.26%	-15.92%	21.25	0.72	-2.44%	-22.68%
BIO	8.0B	2.7B	-22.01%	-40.57%	-12.55	2.99	-4.68%	82.43%
XRAY	6.3B	4.0B	-9.58%	-29.21%	-46.51	1.58	1.10%	85.84%
AXNX	3.4B	387.1M	-3.48%	13.50%	-214.28	8.81	30.82%	65.60%
PDCO	2.3B	6.6B	-7.88%	-6.70%	11.79	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-14.42%	-16.17%	-1.97	0.42	7.73%	-1066.14%
ANIK	392.1M	166.7M	1.93%	-0.42%	-4.74	2.35	6.67%	-456.34%
ANGO	231.9M	324.0M	-1.36%	-32.67%	-1.21	0.72	-3.19%	-337.41%
APYX	49.5M	52.3M	5.15%	-61.35%	-2.65	0.95	17.61%	19.28%
AEMD	3.6M	3.7M	-17.86%	283.33%	-0.3	0.96	5.77%	8.23%

Electromed Inc News

Latest updates

Electromed Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	11.1%	13,689	12,324	13,612	12,068	11,729	10,658	11,269	10,141	10,248	10,001	9,469	8,787	9,496	8,004	6,878	8,744	8,547	8,302	8,604	7,408	8,012
Cost Of Revenue	11.3%	3,144	2,826	3,162	3,012	3,047	2,327	3,151	2,398	2,368	2,300	2,538	2,086	1,971	1,856	1,289	2,150	1,871	1,960	1,935	1,833	1,950
Gross Profit	11.0%	10,545	9,498	10,450	9,056	8,682	8,331	8,118	7,743	7,880	7,701	6,931	6,701	7,525	6,148	5,589	6,594	6,676	6,342	6,668	5,574	6,062
Operating Expenses	-11.5%	8,282	9,356	8,956	7,860	7,408	8,287	7,623	6,880	6,804	7,163	6,280	6,458	5,942	5,485	4,299	5,680	5,109	4,994	5,180	5,110	5,387
S&GA Expenses	-10.7%	8,175	9,150	8,658	7,694	7,254	7,989	7,308	6,544	6,475	6,787	5,953	6,051	5,435	5,004	4,797	5,288	4,965	4,895	5,073	4,939	5,150
R&D Expenses	-48.1%	107	206	298	166	154	298	315	336	329	376	327	407	507	481	416	392	143	99.00	107	171	238
EBITDA Margin	19.7%	0.12*	0.10*	0.10*	0.08*	0.07*	0.07*	0.08*	0.09*	0.08*	0.09*	0.10*	0.13*	-	-	-	-	-	-	-	-	-
Interest Expenses	24.7%	96.00	77.00	41.00	26.00	7.00	4.00	4.00	6.00	6.00	9.00	-1.85	10.00	10.00	9.00	10.00	34.00	37.00	40.00	33.00	27.00	17.00
Income Taxes	970.3%	685	64.00	516	147	304	-60.00	327	224	-6.00	-64.00	578	29.00	-10.00	-120	-9.00	294	419	374	432	139	311
Earnings Before Taxes	977.2%	2,359	219	1,535	1,222	1,281	48.00	499	869	1,082	547	650	253	1,593	672	1,299	947	1,604	1,389	1,522	492	692
EBT Margin	20.6%	0.10*	0.09*	0.09*	0.07*	0.06*	0.06*	0.07*	0.08*	0.07*	0.08*	0.09*	0.12*	-	-	-	-	-	-	-	-	-
Net Income	980.0%	1,674	155	1,033	1,075	977	81.00	383	645	838	439	400	224	1,204	535	1,308	653	1,185	1,015	1,090	353	381
Net Income Margin	16.9%	0.08*	0.07*	0.07*	0.06*	0.05*	0.05*	0.06*	0.06*	0.05*	0.06*	0.07*	0.10*	-	-	-	-	-	-	-	-	-
Free Cashflow	1063.2%	3,400	-353	572	112	918	-1,935	-1,184	-310	184	-801	571	782	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	6.6%	47.00	44.00	46.00	43.00	41.00	40.00	41.00	39.00	38.00	38.00	37.00	37.00	36.00	34.00	33.00	33.00	31.00	30.00	29.00	28.00	27.00
Current Assets	8.5%	39.00	36.00	38.00	35.00	34.00	33.00	35.00	33.00	32.00	32.00	32.00	32.00	31.00	29.00	28.00	28.00	26.00	25.00	25.00	24.00	23.00
Cash Equivalents	48.5%	10.00	7.00	7.00	7.00	7.00	6.00	8.00	10.00	10.00	11.00	12.00	13.00	12.00	11.00	10.00	10.00	9.00	8.00	8.00	8.00	7.00
Inventory	6.3%	5.00	4.00	4.00	3.00	3.00	4.00	3.00	2.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Net PPE	-2.8%	5.00	6.00	6.00	6.00	5.00	5.00	5.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	3.00	3.00
Liabilities	13.3%	7.00	6.00	8.00	6.00	6.00	6.00	7.00	5.00	5.00	5.00	5.00	4.00	3.00	4.00	3.00	4.00	3.00	3.00	4.00	-	-
Current Liabilities	13.8%	7.00	6.00	8.00	6.00	6.00	6.00	7.00	5.00	5.00	5.00	5.00	4.00	3.00	4.00	3.00	4.00	3.00	3.00	4.00	3.00	3.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Shareholder's Equity	5.5%	40.00	38.00	38.00	36.00	35.00	34.00	34.00	34.00	33.00	33.00	32.00	32.00	33.00	31.00	30.00	29.00	28.00	27.00	26.00	24.00	24.00
Retained Earnings	8.8%	21.00	19.00	19.00	18.00	17.00	16.00	16.00	16.00	16.00	15.00	15.00	16.00	15.00	14.00	14.00	12.00	12.00	11.00	10.00	8.00	8.00
Additional Paid-In Capital	2.3%	20.00	19.00	19.00	19.00	19.00	18.00	18.00	18.00	18.00	18.00	17.00	17.00	17.00	17.00	16.00	17.00	17.00	16.00	16.00	16.00	16.00
Shares Outstanding	0.3%	9.00	9.00	9.00	9.00	8.00	8.00	8.00	8.00	8.00	9.00	9.00	9.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	81.00	-	-	-	92.00	-	-	-	71.00	-	-	-	61.00	-	-	-	35.00

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	1522.5%	3,471	-244	999	646	1,364	-1,694	-739	159	470	-576	753	833	669	822	1,284	889	1,395	629	1,418	351	518
Share Based Compensation	13.2%	420	371	202	190	221	95.00	273	177	277	249	268	326	239	191	225	232	234	210	195	229	244
Cashflow From Investing	34.6%	-87.00	-133	-441	-558	-461	-256	-459	-486	-310	-270	-240	-64.00	-62.00	-82.00	-126	-149	-285	-415	-1,145	-89.62	-118
Cashflow From Financing	-10.3%	26.00	29.00	38.00	-221	8.00	-205	-493	-299	-670	-63.00	-1,124	-11.00	-8.00	-76.00	-611	-12.51	63.00	13.00	-	63.00	-934
Buy Backs	-	-	-	-	-	8.00	145	486	299	663	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ELMD Income Statement

2023-12-31

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net revenues	$ 13,689,000	$ 11,729,000	$ 26,013,000	$ 22,387,000
Cost of revenues	3,144,000	3,047,000	5,970,000	5,374,000
Gross profit	10,545,000	8,682,000	20,043,000	17,013,000
Operating expenses
Selling, general and administrative	8,175,000	7,254,000	17,325,000	15,243,000
Research and development	107,000	154,000	313,000	452,000
Total operating expenses	8,282,000	7,408,000	17,638,000	15,695,000
Operating income	2,263,000	1,274,000	2,405,000	1,318,000
Interest income, net	96,000	7,000	173,000	11,000
Net income before income taxes	2,359,000	1,281,000	2,578,000	1,329,000
Income tax expense	685,000	304,000	749,000	271,000
Net income	$ 1,674,000	$ 977,000	$ 1,829,000	$ 1,058,000
Income per share:
Basic	$ 0.20	$ 0.12	$ 0.21	$ 0.13
Diluted	$ 0.19	$ 0.11	$ 0.21	$ 0.12
Weighted-average common shares outstanding:
Basic	8,545,120	8,442,939	8,541,254	8,442,684
Diluted	8,800,172	8,684,352	8,791,519	8,685,184

ELMD Balance Sheet

2023-12-31

Condensed Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current Assets
Cash and cash equivalents	$ 10,434,000	$ 7,372,000
Accounts receivable (net of allowances for doubtful accounts of $45,000)	22,988,000	24,130,000
Contract assets	574,000	487,000
Inventories	4,760,000	4,221,000
Prepaid expenses and other current assets	509,000	1,577,000
Total current assets	39,265,000	37,787,000
Property and equipment, net	5,377,000	5,672,000
Finite-life intangible assets, net	616,000	605,000
Other assets	125,000	161,000
Deferred income taxes	1,581,000	1,581,000
Total assets	46,964,000	45,806,000
Current Liabilities
Accounts payable	1,041,000	1,372,000
Accrued compensation	2,806,000	3,018,000
Income tax payable	253,000	336,000
Warranty reserve	1,483,000	1,378,000
Other accrued liabilities	990,000	1,949,000
Total current liabilities	6,573,000	8,053,000
Other long-term liabilities	49,000	86,000
Total liabilities	6,622,000	8,139,000
Shareholders’ Equity
Common stock, $0.01 par value per share, 13,000,000 shares authorized; 8,602,677 and 8,555,238 shares issued and outstanding, as of December 31, 2023 and June 30, 2023, respectively	86,000	86,000
Additional paid-in capital	19,634,000	18,788,000
Retained earnings	20,622,000	18,793,000
Total shareholders’ equity	40,342,000	37,667,000
Total liabilities and shareholders’ equity	$ 46,964,000	$ 45,806,000

About Electromed Inc

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

CEO	Mr. James L. Cunniff
WEBSITE	https://smartvest.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	170

Electromed Inc Frequently Asked Questions

What is the ticker symbol for Electromed Inc? What does ELMD stand for in stocks?

ELMD is the stock ticker symbol of Electromed Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Electromed Inc (ELMD)?

As of Tue Apr 30 2024, market cap of Electromed Inc is 149.64 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ELMD stock?

You can check ELMD's fair value in chart for subscribers.

What is the fair value of ELMD stock?

You can check ELMD's fair value in chart for subscribers. The fair value of Electromed Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Electromed Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ELMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Electromed Inc a good stock to buy?

The fair value guage provides a quick view whether ELMD is over valued or under valued. Whether Electromed Inc is cheap or expensive depends on the assumptions which impact Electromed Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ELMD.

What is Electromed Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, ELMD's PE ratio (Price to Earnings) is 38.01 and Price to Sales (PS) ratio is 2.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ELMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Electromed Inc's stock?

In the past 10 years, Electromed Inc has provided 0.297 (multiply by 100 for percentage) rate of return.